Therapeutic Advances in Neurological Disorders · 2011 · 399 citations · 150 references
MedicinePharmacologyPharmacotherapyEpilepsyNeuropsychiatryNeuropsychologyAntiepileptic PharmacologyAntiepileptic PharmacotherapyCognitive AssessmentCognitive ImpairmentExecutive DysfunctionExecutive Function AssessmentAntiepileptic Drug EfficacyCognitive Adverse EffectsCognitive EffectsCognitive Effects Of EpilepsyComplianceMedication Effects On CognitionNeuropsychological FunctioningTreatment Outcomes In Epilepsy
Effective treatment of epilepsy depends on medication compliance across a lifetime, and studies indicate that drug tolerability is a significant limiting factor in medication maintenance. Available antiepileptic drugs (AEDs) have the potential to exert detrimental effects on cognitive function and therefore compromise patient wellbeing. On the other hand, some agents may serve to enhance cognitive function. In this review paper, we highlight the range of effects on cognition linked to a variety of newer and older AEDs, encompassing key alterations in both specific executive abilities and broader neuropsychological functions. Importantly, the data reviewed suggest that the effects exerted by an AED could vary depending on both patient characteristics and drug-related variables. However, there are considerable difficulties in evaluating the available evidence. Many studies have failed to investigate the influence of patient and treatment variables on cognitive functioning. Other difficulties include variation across studies in relation to design, treatment group and assessment tools, poor reporting of methodology and poor specification of the cognitive abilities assessed. Focused and rigorous experimental designs including a range of cognitive measures assessing more precisely defined abilities are needed to fill the gaps in our knowledge and follow up reported patterns in the literature. Longitudinal studies are needed to improve our understanding of the influence of factors such as age, tolerance and the stability of cognitive effects. Future trials comparing the effects of commonly prescribed agents across patient subgroups will offer critical insight into the role of patient characteristics in determining the cognitive impact of particular AEDs.
150
Ethosuximide, Valproic Acid, and Lamotrigine in Childhood Absence Epilepsy
Tracy A. Glauser, Avital Cnaan, Shlomo Shinnar et al. · New England Journal of Medicine · 2010 · 638 citations · Full text
Outcomes of Add‐on Treatment with Lamotrigine in Partial Epilepsy
David F. Smith, Gus A. Baker, Gary Davies et al. · Epilepsia · 1993 · 333 citations